Sartorius: US fully embracing single-use as bioprocess unit leads 13% growth
The US has caught up with Europe in adopting single-use technologies, says Sartorius which reported a 32% growth in sales for the region in 2014.
Archives for January 29, 2015
Tysabri plant to make Samsung's Enbrel biosimilar for European market
Biogen Idec will make Samsung Bioepis’ Enbrel (etanercept) biosimilar at the Danish plant that supplies its originator products, Tysabri (natalizumab) and Avonex (interferon beta-1a).